YOKNEAM, Israel, April 29, 2015 /PRNewswire/ -- Syneron
Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device
company, today announced that it will release first quarter 2015
financial results before the market opens on Wednesday, May 13, 2015. The earnings release
will be available on Syneron's website at
www.investors.syneron.com.
Syneron management will host a conference call and a live
webcast at 8:30 a.m. (ET) on the same
day. A question & answer session will follow management's
discussion of events in the first quarter 2015.
Investors and analysts may participate in the conference call
using the following dial-in numbers:
US (toll free): (877) 280-2296
International: (212) 444 0412
The conference passcode for both is 8072668.
Investors and other interested parties can also access a live
webcast of the conference call through the Investor Relations page
on Syneron's website at www.investors.syneron.com. Please log-in at
least 10 minutes prior to the conference call in order to download
the applicable audio software. Following the conclusion of the
call, a replay of the webcast will be available within 24 hours on
the Company's website.
About Syneron Candela:
Syneron Candela is a
leading global aesthetic device company with a comprehensive
product portfolio and a global distribution footprint. The
Company's technology enables physicians to provide advanced
solutions for a broad range of medical-aesthetic applications
including non-invasive fat destruction, body contouring, hair
removal, wrinkle reduction, tattoo removal, improving the skin's
appearance through the treatment of superficial benign vascular and
pigmented lesions, and the treatment of acne, leg veins and
cellulite. The Company sells its products under three distinct
brands, Syneron, Candela and CoolTouch, and has a wide portfolio of
trusted, leading products including UltraShape, VelaShape,
GentleLase, VBeam Perfecta, PicoWay and elos Plus.
Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Candela are located in Israel.
Syneron Candela also has R&D and manufacturing operations in
the U.S. The company markets, services and supports its
products in 86 countries. It has offices in North
America, France, Germany, Italy, Portugal, Spain,
UK, Australia,China, Japan, and Hong Kong and
distributors worldwide.
For additional information, please
visit http://www.syneron-candela.com.
Logo - http://photos.prnewswire.com/prnh/20120528/535447
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/syneron-medical-to-report-first-quarter-2015-financial-results-on-may-13-2015-300074202.html
SOURCE Syneron Medical Ltd.